Logo image of LYB

LYONDELLBASELL INDU-CL A (LYB) Stock Fundamental Analysis

USA - NYSE:LYB - NL0009434992 - Common Stock

45.3 USD
-0.22 (-0.48%)
Last: 11/14/2025, 8:04:00 PM
45.49 USD
+0.19 (+0.42%)
After Hours: 11/14/2025, 8:04:00 PM
Fundamental Rating

3

LYB gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 82 industry peers in the Chemicals industry. LYB has a bad profitability rating. Also its financial health evaluation is rather negative. LYB has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year LYB was profitable.
LYB had a positive operating cash flow in the past year.
In the past 5 years LYB has always been profitable.
In the past 5 years LYB always reported a positive cash flow from operatings.
LYB Yearly Net Income VS EBIT VS OCF VS FCFLYB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

1.2 Ratios

LYB has a worse Return On Assets (-3.59%) than 68.29% of its industry peers.
LYB has a Return On Equity of -11.44%. This is in the lower half of the industry: LYB underperforms 68.29% of its industry peers.
With a Return On Invested Capital value of 3.64%, LYB perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
LYB had an Average Return On Invested Capital over the past 3 years of 10.69%. This is above the industry average of 6.09%.
The 3 year average ROIC (10.69%) for LYB is well above the current ROIC(3.64%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -3.59%
ROE -11.44%
ROIC 3.64%
ROA(3y)6.72%
ROA(5y)7.89%
ROE(3y)19.31%
ROE(5y)24.61%
ROIC(3y)10.69%
ROIC(5y)11.69%
LYB Yearly ROA, ROE, ROICLYB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

1.3 Margins

LYB's Profit Margin has declined in the last couple of years.
LYB's Operating Margin of 3.65% is on the low side compared to the rest of the industry. LYB is outperformed by 68.29% of its industry peers.
In the last couple of years the Operating Margin of LYB has declined.
LYB has a worse Gross Margin (9.19%) than 82.93% of its industry peers.
LYB's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.65%
PM (TTM) N/A
GM 9.19%
OM growth 3Y-24.61%
OM growth 5Y-10.5%
PM growth 3Y-34.85%
PM growth 5Y-19.21%
GM growth 3Y-15.85%
GM growth 5Y-6.35%
LYB Yearly Profit, Operating, Gross MarginsLYB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so LYB is still creating some value.
LYB has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, LYB has less shares outstanding
The debt/assets ratio for LYB is higher compared to a year ago.
LYB Yearly Shares OutstandingLYB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
LYB Yearly Total Debt VS Total AssetsLYB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

LYB has an Altman-Z score of 1.90. This is not the best score and indicates that LYB is in the grey zone with still only limited risk for bankruptcy at the moment.
LYB has a Altman-Z score of 1.90. This is comparable to the rest of the industry: LYB outperforms 56.10% of its industry peers.
LYB has a debt to FCF ratio of 16.07. This is a negative value and a sign of low solvency as LYB would need 16.07 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 16.07, LYB is in line with its industry, outperforming 54.88% of the companies in the same industry.
A Debt/Equity ratio of 1.02 is on the high side and indicates that LYB has dependencies on debt financing.
LYB has a Debt to Equity ratio of 1.02. This is in the lower half of the industry: LYB underperforms 64.63% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 16.07
Altman-Z 1.9
ROIC/WACC0.48
WACC7.63%
LYB Yearly LT Debt VS Equity VS FCFLYB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

LYB has a Current Ratio of 1.57. This is a normal value and indicates that LYB is financially healthy and should not expect problems in meeting its short term obligations.
LYB's Current ratio of 1.57 is on the low side compared to the rest of the industry. LYB is outperformed by 69.51% of its industry peers.
A Quick Ratio of 0.93 indicates that LYB may have some problems paying its short term obligations.
LYB has a worse Quick ratio (0.93) than 69.51% of its industry peers.
Industry RankSector Rank
Current Ratio 1.57
Quick Ratio 0.93
LYB Yearly Current Assets VS Current LiabilitesLYB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2

3. Growth

3.1 Past

LYB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -61.51%.
The Earnings Per Share has been decreasing by -7.75% on average over the past years.
LYB shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -20.07%.
The Revenue has been growing slightly by 3.02% on average over the past years.
EPS 1Y (TTM)-61.51%
EPS 3Y-29.4%
EPS 5Y-7.75%
EPS Q2Q%-46.28%
Revenue 1Y (TTM)-20.07%
Revenue growth 3Y-4.43%
Revenue growth 5Y3.02%
Sales Q2Q%-25.14%

3.2 Future

The Earnings Per Share is expected to grow by 5.03% on average over the next years.
Based on estimates for the next years, LYB will show a decrease in Revenue. The Revenue will decrease by -6.25% on average per year.
EPS Next Y-61.2%
EPS Next 2Y-21.33%
EPS Next 3Y-6.1%
EPS Next 5Y5.03%
Revenue Next Year-25.71%
Revenue Next 2Y-13.82%
Revenue Next 3Y-8.97%
Revenue Next 5Y-6.25%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
LYB Yearly Revenue VS EstimatesLYB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B 40B 50B
LYB Yearly EPS VS EstimatesLYB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5 10 15

4

4. Valuation

4.1 Price/Earnings Ratio

LYB is valuated correctly with a Price/Earnings ratio of 16.72.
LYB's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 25.89, LYB is valued a bit cheaper.
Based on the Price/Forward Earnings ratio of 11.44, the valuation of LYB can be described as reasonable.
Based on the Price/Forward Earnings ratio, LYB is valued a bit cheaper than 75.61% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.59, LYB is valued rather cheaply.
Industry RankSector Rank
PE 16.72
Fwd PE 11.44
LYB Price Earnings VS Forward Price EarningsLYB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as LYB.
LYB's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. LYB is cheaper than 65.85% of the companies in the same industry.
Industry RankSector Rank
P/FCF 19.74
EV/EBITDA 9.49
LYB Per share dataLYB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

A cheap valuation may be justified as LYB's earnings are expected to decrease with -6.10% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-21.33%
EPS Next 3Y-6.1%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 12.04%, LYB is a good candidate for dividend investing.
LYB's Dividend Yield is rather good when compared to the industry average which is at 4.00. LYB pays more dividend than 97.56% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.44, LYB pays a better dividend.
Industry RankSector Rank
Dividend Yield 12.04%

5.2 History

The dividend of LYB has a limited annual growth rate of 5.17%.
LYB has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of LYB decreased recently.
Dividend Growth(5Y)5.17%
Div Incr Years1
Div Non Decr Years1
LYB Yearly Dividends per shareLYB Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8

5.3 Sustainability

The earnings of LYB are negative and hence is the payout ratio. LYB will probably not be able to sustain this dividend level.
The dividend of LYB is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP-144.93%
EPS Next 2Y-21.33%
EPS Next 3Y-6.1%
LYB Yearly Income VS Free CF VS DividendLYB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

LYONDELLBASELL INDU-CL A

NYSE:LYB (11/14/2025, 8:04:00 PM)

After market: 45.49 +0.19 (+0.42%)

45.3

-0.22 (-0.48%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)10-31 2025-10-31/bmo
Earnings (Next)01-29 2026-01-29/amc
Inst Owners74.62%
Inst Owner Change-6.6%
Ins Owners0.18%
Ins Owner Change0%
Market Cap14.57B
Revenue(TTM)32.56B
Net Income(TTM)-1.21B
Analysts63.85
Price Target58.71 (29.6%)
Short Float %6.91%
Short Ratio3.94
Dividend
Industry RankSector Rank
Dividend Yield 12.04%
Yearly Dividend5.31
Dividend Growth(5Y)5.17%
DP-144.93%
Div Incr Years1
Div Non Decr Years1
Ex-Date08-25 2025-08-25 (1.37)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.36%
Min EPS beat(2)-23.45%
Max EPS beat(2)24.17%
EPS beat(4)2
Avg EPS beat(4)-4.8%
Min EPS beat(4)-23.45%
Max EPS beat(4)24.17%
EPS beat(8)4
Avg EPS beat(8)-1.26%
EPS beat(12)8
Avg EPS beat(12)5.26%
EPS beat(16)10
Avg EPS beat(16)2.78%
Revenue beat(2)2
Avg Revenue beat(2)2.02%
Min Revenue beat(2)0.76%
Max Revenue beat(2)3.27%
Revenue beat(4)4
Avg Revenue beat(4)1.93%
Min Revenue beat(4)0.76%
Max Revenue beat(4)3.27%
Revenue beat(8)6
Avg Revenue beat(8)0.64%
Revenue beat(12)7
Avg Revenue beat(12)-0.64%
Revenue beat(16)10
Avg Revenue beat(16)0.42%
PT rev (1m)-4.07%
PT rev (3m)-13.41%
EPS NQ rev (1m)-3.65%
EPS NQ rev (3m)-15.51%
EPS NY rev (1m)-1.8%
EPS NY rev (3m)-26.15%
Revenue NQ rev (1m)-3.17%
Revenue NQ rev (3m)-3.57%
Revenue NY rev (1m)-0.33%
Revenue NY rev (3m)-1.53%
Valuation
Industry RankSector Rank
PE 16.72
Fwd PE 11.44
P/S 0.45
P/FCF 19.74
P/OCF 5.46
P/B 1.37
P/tB 1.54
EV/EBITDA 9.49
EPS(TTM)2.71
EY5.98%
EPS(NY)3.96
Fwd EY8.74%
FCF(TTM)2.29
FCFY5.06%
OCF(TTM)8.3
OCFY18.32%
SpS101.22
BVpS32.95
TBVpS29.34
PEG (NY)N/A
PEG (5Y)N/A
Graham Number44.82
Profitability
Industry RankSector Rank
ROA -3.59%
ROE -11.44%
ROCE 4.41%
ROIC 3.64%
ROICexc 3.89%
ROICexgc 4.08%
OM 3.65%
PM (TTM) N/A
GM 9.19%
FCFM 2.27%
ROA(3y)6.72%
ROA(5y)7.89%
ROE(3y)19.31%
ROE(5y)24.61%
ROIC(3y)10.69%
ROIC(5y)11.69%
ROICexc(3y)11.83%
ROICexc(5y)12.68%
ROICexgc(3y)12.95%
ROICexgc(5y)13.92%
ROCE(3y)12.98%
ROCE(5y)14.24%
ROICexgc growth 3Y-25.81%
ROICexgc growth 5Y-9.22%
ROICexc growth 3Y-25.6%
ROICexc growth 5Y-8.64%
OM growth 3Y-24.61%
OM growth 5Y-10.5%
PM growth 3Y-34.85%
PM growth 5Y-19.21%
GM growth 3Y-15.85%
GM growth 5Y-6.35%
F-Score3
Asset Turnover0.96
Health
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 16.07
Debt/EBITDA 4.18
Cap/Depr 138.59%
Cap/Sales 5.93%
Interest Coverage 250
Cash Conversion 103.45%
Profit Quality N/A
Current Ratio 1.57
Quick Ratio 0.93
Altman-Z 1.9
F-Score3
WACC7.63%
ROIC/WACC0.48
Cap/Depr(3y)123.27%
Cap/Depr(5y)130.2%
Cap/Sales(3y)4.01%
Cap/Sales(5y)4.66%
Profit Quality(3y)139.02%
Profit Quality(5y)124.38%
High Growth Momentum
Growth
EPS 1Y (TTM)-61.51%
EPS 3Y-29.4%
EPS 5Y-7.75%
EPS Q2Q%-46.28%
EPS Next Y-61.2%
EPS Next 2Y-21.33%
EPS Next 3Y-6.1%
EPS Next 5Y5.03%
Revenue 1Y (TTM)-20.07%
Revenue growth 3Y-4.43%
Revenue growth 5Y3.02%
Sales Q2Q%-25.14%
Revenue Next Year-25.71%
Revenue Next 2Y-13.82%
Revenue Next 3Y-8.97%
Revenue Next 5Y-6.25%
EBIT growth 1Y-60.92%
EBIT growth 3Y-27.96%
EBIT growth 5Y-7.79%
EBIT Next Year-5.52%
EBIT Next 3Y10.46%
EBIT Next 5Y10.29%
FCF growth 1Y-79.05%
FCF growth 3Y-29.85%
FCF growth 5Y-2.67%
OCF growth 1Y-47.04%
OCF growth 3Y-20.83%
OCF growth 5Y-5.1%

LYONDELLBASELL INDU-CL A / LYB FAQ

Can you provide the ChartMill fundamental rating for LYONDELLBASELL INDU-CL A?

ChartMill assigns a fundamental rating of 3 / 10 to LYB.


What is the valuation status for LYB stock?

ChartMill assigns a valuation rating of 4 / 10 to LYONDELLBASELL INDU-CL A (LYB). This can be considered as Fairly Valued.


How profitable is LYONDELLBASELL INDU-CL A (LYB) stock?

LYONDELLBASELL INDU-CL A (LYB) has a profitability rating of 4 / 10.


What are the PE and PB ratios of LYONDELLBASELL INDU-CL A (LYB) stock?

The Price/Earnings (PE) ratio for LYONDELLBASELL INDU-CL A (LYB) is 16.72 and the Price/Book (PB) ratio is 1.37.


How sustainable is the dividend of LYONDELLBASELL INDU-CL A (LYB) stock?

The dividend rating of LYONDELLBASELL INDU-CL A (LYB) is 5 / 10 and the dividend payout ratio is -144.93%.